Latest fiscal year 2026 · computed deterministically from XBRL 10-K data · coverage 100%
In fiscal 2026, Akso Health Group reported revenue of $14M, down 6.4% year over year. Operating margin was -149.7% and net margin -135.0%, on a free-cash-flow margin of -92.5% with capital expenditure at 0.0% of revenue. Every figure is computed directly from AHG's SEC XBRL 10-K filing — deterministic, with no estimates.
| Fiscal year | Revenue | Op margin | Net margin |
|---|---|---|---|
| FY2026 | $14M | -149.7% | -135.0% |
| FY2025 | $15M | -1125.4% | -913.4% |
| FY2024 | $2M | -357.8% | -391.8% |
| FY2023 | $13M | -108.2% | -10.3% |
| FY2022 | $6M | -51.7% | -267.0% |
How does AHG compare against its actual peer set?
A CompsDesk subscription covers unlimited benchmark packs on any covered company: up to 19 metrics (6 core guaranteed) × up to 5 fiscal years × up to 12 chosen peers, percentile placement, the subject's figures cited to their SEC tag, form and period with every company identified by its CIK, PDF-ready HTML + CSV, generated on demand.
Source: SEC EDGAR XBRL (10-K filings), latest filed values. "n/a" = not disclosed under mapped tags — never estimated. Informational benchmarking, not investment advice. © CompsDesk / Sam Arora.